Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Oralin dossier submitted to the Ecuador Ministry of Public Health
September 27th, 2004
Generex Biotechnology Corp. (GNBT), a buccal drug-delivery company, announced that, in furtherance of its previously announced joint venture with PharmaBrand, SA, the Oralin dossier has been submitted to the Ecuador Ministry of Public Health seeking approval for the manufacture, marketing, distribution, and sale of Oralin. Oralin is the company's proprietary oral insulin spray formulation, as well as the company's proprietary RapidMist Diabetes Management System. "We are very pleased to have taken this important first step towards the global registration of Oralin," said Anna Gluskin, president and CEO of Generex. "We are optimistic about the...
Source: Obesity & Diabetes Week (2004-09-27)
|
